Subsequently, we identified IGF2BP1 as the candidate for miR-31-5p/miR-27b-3p target gene for its upregulated expression associated with poor OS in patients with BC (Additional file 1: Fig. S7B). Here, IGF2BP1 is linked to breast cancer.